-  - Var. - Volume Denaro03:01:05 Lettera03:01:05 Capitalizzazione di mercato Dividend Y. Rapporto P/E
179.30EUR - -
Fatturato: -
-Quantità in denaro: - -Quantità in lettera: - 16.53 bill.EUR 0.38% 53.36

Descrizione business

Sartorius Stedim Biotech is a leading international supplier of products and services that enable the biopharmaceutical industry to develop and manufacture drugs safely and efficiently. As a total solutions provider, Sartorius Stedim Biotech offers a portfolio covering nearly all steps of biopharmaceutical manufacture. The company focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Headquartered in Aubagne, France, Sartorius Stedim Biotech is quoted on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and an international network of sales companies, Sartorius Stedim Biotech has a global reach.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Dr. Joachim Kreuzburg
Consiglio di amministrazione
Alexandra Gatzemeyer, Dr. René Fáber
Consiglio di sorveglianza
Joachim Kreuzburg, René Fáber, Pascale Boissel, Susan Dexter, Romaine Fernandes, Anne-Marie Graffin, Lothar Kappich, Henri Riey
 

Dati aziendali

Name: Sartorius Stedim Biotech SA
Indirizzo: Avenue de Jouques - CS 91051,F-13781 Aubagne Cedex
Telefono: +33-442-84-5600
Fax: +33-442-84-5619
E-mail: info@sartorius-stedim.com
Internet: https://www.sartorius.com/en/company/about-sartorius-stedim-biotech-sa
Industria: Biotechnology
Settore: Biotechnology
Sub settore: Biotechnology
Fine dell'anno finanziario: 31/12
Flottante libero: 26.20%
Data dell'IPO: -

Rapporti con gli investitori

Name: Petra Kirchhoff
IR telefono: +49-551-308-1686
IR Fax: -
IR e-mail: petra.kirchhoff@sartorius.com

Company calendar

CW 29 | 19/07/2024 Interim Report 2nd Quarter/6 Months
CW 42 | 17/10/2024 Interim Report 3rd Quarter/9 Months
 

Principali azionisti

Sartorius AG
 
73.60%
free float
 
26.40%